Based on our LN simulations, we hypothesized that we would have greater levels of T cells or greater percentages of PD-1- T cells within tumor-draining LNs of mice treated with 25% PD-1+ T cells based on these results. The gene discussed is PDCD1; the disease is neoplasm.